KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Jan 23, 2026 >>  ABB India 4691.75  [ -1.39% ]  ACC 1670.35  [ -3.32% ]  Ambuja Cements 518.85  [ -5.01% ]  Asian Paints Ltd. 2702.25  [ -0.03% ]  Axis Bank Ltd. 1260.1  [ -2.72% ]  Bajaj Auto 9413.3  [ 0.51% ]  Bank of Baroda 296.2  [ -2.95% ]  Bharti Airtel 1985.25  [ -0.84% ]  Bharat Heavy Ele 242.5  [ -3.60% ]  Bharat Petroleum 349.3  [ -1.37% ]  Britannia Ind. 5834.1  [ -1.66% ]  Cipla 1314.85  [ -4.13% ]  Coal India 418.55  [ -1.08% ]  Colgate Palm 2164.95  [ -0.67% ]  Dabur India 518.65  [ -1.25% ]  DLF Ltd. 588.6  [ -4.08% ]  Dr. Reddy's Labs 1235.15  [ 1.48% ]  GAIL (India) 161.15  [ -1.47% ]  Grasim Inds. 2760.4  [ -1.00% ]  HCL Technologies 1706.6  [ 0.23% ]  HDFC Bank 916.25  [ -0.34% ]  Hero MotoCorp 5391.55  [ -1.75% ]  Hindustan Unilever 2412.05  [ 0.92% ]  Hindalco Indus. 950.3  [ 0.60% ]  ICICI Bank 1343.35  [ -0.17% ]  Indian Hotels Co 644.9  [ -1.78% ]  IndusInd Bank 893.1  [ -1.04% ]  Infosys L 1670.6  [ 0.44% ]  ITC Ltd. 323.45  [ -0.45% ]  Jindal Steel 1063.05  [ -1.24% ]  Kotak Mahindra Bank 422.2  [ -0.85% ]  L&T 3745.05  [ -1.30% ]  Lupin Ltd. 2137.15  [ -1.29% ]  Mahi. & Mahi 3542.6  [ -0.84% ]  Maruti Suzuki India 15469.6  [ -1.87% ]  MTNL 29.02  [ -4.26% ]  Nestle India 1293.3  [ -0.96% ]  NIIT Ltd. 73.99  [ -3.47% ]  NMDC Ltd. 76.4  [ -2.39% ]  NTPC 336.8  [ -1.66% ]  ONGC 245.55  [ 0.64% ]  Punj. NationlBak 120.15  [ -4.00% ]  Power Grid Corpo 254.2  [ -2.06% ]  Reliance Inds. 1385.95  [ -1.13% ]  SBI 1029.4  [ -1.80% ]  Vedanta 684.4  [ 0.87% ]  Shipping Corpn. 201.8  [ -2.70% ]  Sun Pharma. 1631.65  [ -0.17% ]  Tata Chemicals 714.1  [ -2.12% ]  Tata Consumer Produc 1153.25  [ -1.87% ]  Tata Motors Passenge 344.2  [ -0.89% ]  Tata Steel 187.55  [ -0.92% ]  Tata Power Co. 345.3  [ -1.95% ]  Tata Consultancy 3160.85  [ 0.30% ]  Tech Mahindra 1701.35  [ 0.79% ]  UltraTech Cement 12368.3  [ 0.03% ]  United Spirits 1333  [ -0.44% ]  Wipro 238.35  [ -0.98% ]  Zee Entertainment En 81.39  [ -4.36% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    AJANTA PHARMA LTD.

    23 January 2026 | 12:00

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE031B01049 BSE Code / NSE Code 532331 / AJANTPHARM Book Value (Rs.) 345.44 Face Value 2.00
    Bookclosure 10/11/2025 52Week High 3080 EPS 73.68 P/E 36.64
    Market Cap. 33721.27 Cr. 52Week Low 2327 P/BV / Div Yield (%) 7.82 / 1.04 Market Lot 1.00
    Security Type Other

    History of Company

    The company history sections lists out major chronological events that happened to the company.
    2005 -Max Healthcare to establish India`s first brain lab in New Delhi -Max India Ltd Max telecom ventures Ltd signed a MoU

    2008 -Max India signs agreement with UK firm for health insurance biz

    2012 -Board declares Interim Dividend of 500% i.e. Rs. 10/- for every equity share of Rs. 2/- each to the shareholders. -Ajanta Pharma Ltd has splits its face value from Rs 10/- to 5/-

    2013 - Board recommends Final Dividend 610% amounting to Rs. 12.20 per equity share of Rs. 2/- each to the shareholders. -Ajanta Pharma has announces bonus in the ratio of 1:2 2014 -Board recommends Final Dividendof 90%, i.e., Rs. 1.80 for every equity share of Rs. 2/- each to the shareholders

    2015 -Ajanta Pharma Announces the Launch of Montelukast Sodium Oral Granules -Launch of Montelukast lR Tablets and Montelukast Chewable Tablets in US market -Fortune India presents award to Ajanta Pharma -Ajanta Pharma gets approvals for 3 ANDA's -Ajanta Pharma has splits its face value from Rs. 5 to Rs. 2

    2017 -Ajanta Pharma gets USFDA nod for Duloxetine Hydrochloride. -Ajanta Pharma launches Eletriptan Hydrobromide Tablets. -Ajanta Pharma launches Clonidine Hydrochloride Extended Release Tablets in US. -Inaugurated & commissioned 1st phase at a New Facility in Guwahati, Assam, India - Dahej facility receives successful US FDA approval.

    2018 -Top Export Performer Award' by the Federation of Indian Export Organisations. -Commissioned Ajanta's 1st ever Derma facility in Guwahati.

    2019 -Ajanta Pharma USA Inc. (APUI) received DIANA award for `Best Overall Generic Manufacturer' in less than $100 mn. -New manufacturing facility for oral solid inaugurated at Pithampur.

    2020 -Ajanta's 1st Sterile Eye Drop Production Unit commissioned at Guwahati Facility.

    2021 -Listed in Fortune 500 list of Indian companies Ranked 379th in Revenue Generation (Dec 2021).

    2022

    -The Company has issued Bonus Shares in the Ratio of 1:2. -Ajanta Pharma awarded 'India's Best Managed Companies' for 2022 by Deloitte. -Ajanta wins 'Maharashtra State Best Employer Brand Awards 2022' in Pharma sector -Ajanta wins Excellence in Packaging Developed in India & Packaging Team of the Year at India Packaging Awards 2022

    2023

    The Company has infomed that, in its meeting scheduled on 10/03/2023 ,inter alia, to consider and approve the proposal for buyback of the equity shares of the Company and matters related / incidental thereto.

    -Ajanta wins 'Outstanding Export Performance Award' from Pharmexcil in 'Formulation' category

    -Ajanta wins 'Excellence in Pharma Supply Chain Management

    - Ajanta wins Times Ascent Global Best Employer Brands 2023

    2024

    -Ajanta Pharma Certified as a great place to work in India for the 2nd year.

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion

    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.